We were concerned that, in the week before the start of the new financial year, the Department had not finalised the allocation of its £9.6 billion Spending Review settlement for COVID-19 response activities, creating uncertainty for the vaccine programme. In the 2021 Spending Review, the Department received £9.6 billion for all its key COVID-19 programmes throughout the three-year spending review period. But when we took evidence on 28 March, the Department still could not tell us how it wou...

We were concerned that, in the week before the start of the new financial year, the Department had not finalised the allocation of its £9.6 billion Spending Review settlement for COVID-19 response activities, creating uncertainty for the vaccine programme. In the 2021 Spending Review, the Department received £9.6 billion for all its key COVID-19 programmes throughout the three-year spending review period. But when we took evidence on 28 March, the Department still could not tell us how it would distribute funding among different programmes for 2022–23, including the vaccine programme. It also had not finalised the 2022–23 budget for UKHSA, wh Type: conclusion | Number: 7 | Response status: not_addressed Government response: 7.1 The government agrees with the Committee’s recommendation Target implementation date: Spring 2023 7.2 Funding for the vaccine procurement and deployment programme is held within DHSC budgets. The delivery responsibility for procurement sits with the Vaccine Ta